MALAT1 and central nervous system cancer: For example, Ma et al. discovered that compared with paired normal tissues, the expression level of lncRNA MALAT1 was increased in glioma tissues, which means MALAT1 can be treated as a convictive marker for the prognosis of glioma patients (Ma et al., 2015).